Intrinsic disorder drives N-terminal ubiquitination by Ube2w

Nature Chemical Biology

Volumn 11, Issue 1, 2015, Pages 83-89

  Vittal, Vinayak ^a   Shi, Lei ^a,b   Wenzel, Dawn M ^a   Scaglione, K Matthew ^c,d   Duncan, Emily D ^a   Basrur, Venkatesha ^c   Elenitoba Johnson, Kojo S J ^c   Baker, David ^a,b   Paulson, Henry L ^c   Brzovic, Peter S ^a   Klevit, Rachel E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BINDING; UBE2W PROTEIN, HUMAN; UBIQUINONE; UBIQUITIN CONJUGATING ENZYME;

CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POINT MUTATION; PROTEIN CONFORMATION; UBIQUITINATION;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY; UBIQUINONE; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION;

EID: 84927544290     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1700     Document Type: Article

References (53)

1. Pickart, C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
2. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
3. Chen, Z. & Pickart, C.M. A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multi-ubiquitin chain synthesis via lysine 48 of ubiquitin. J. Biol. Chem. 265, 21835-21842 (1990).
4. Brzovic, P.S. & Klevit, R.E. Ubiquitin transfer from the E2 perspective: why is UbcH5c so promiscuous? Cell Cycle 5, 2867-2873 (2006).
5. Nuber, U., Schwarz, S., Kaiser, P., Schneider, R. & Schefner, M. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction E6-AP and RSP5. J. Biol. Chem. 271, 2795-2800 (1996).
6. Machida, Y.J. et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23, 589-596 (2006).
7. McDowell, G.S., Kucerova, R. & Philpott, A. Non-canonical ubiquitylation of the proneural protein Ngn2 occurs in both Xenopus embryos and mammalian cells. Biochem. Biophys. Res. Commun. 400, 655-660 (2010).
8. Vosper, J.M. et al. Ubiquitylation on canonical and non-canonical sties targets the transcription factor neurogenin for ubiquitin-mediate proteolysis. J. Biol. Chem. 284, 15458-15468 (2009).
9. Scaglione, K.M. et al. Te ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N terminus of substrates. J. Biol. Chem. 288, 18784-18788 (2013).
10. Tatham, M.H., Plechanovová, A., Jafray, E.G., Salmen, H. & Hay, R.T. Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. Biochem. J. 453, 137-145 (2013).
11. Wu, W. et al. BRCA1 ubiquitinates RPB8 in response to DNA damage. Cancer Res. 67, 951-958 (2007).
12. Christensen, D.E., Brzovic, P.S. & Klevit, R.E. E2-BRCA1 RING interactions dictate synthesis of mono-or specifc polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 14, 941-948 (2007).
13. Guzzo, C.M. et al. RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to site of DNA damage. Sci. Signal. 5, ra88 (2012).
14. Wenzel, D.M., Lissounov, A., Brzovic, P.S. & Klevit, R.E. UBCH7 reactivity profle reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108 (2011).
15. Zhang, Y. et al. UBE2W interacts with FANCL and regulates the monoubiquitination of Fanconi anemia protein FANCD2. Mol. Cells 31, 113-122 (2011).
16. Alpi, A.F., Pace, P.E., Babu, M.M. & Patel, K.J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767-777 (2008).
17. 13C-relaxation studies of randomly fractionally labeled protein. Biochemistry 35, 6116-6125 (1996).
18. Berman, H.M. et al. Te Protein Data Bank. Nucleic Acids Res. 28, 235-242 (2000).
19. Kelley, L.A. & Sternberg, M.J.E. Protein structure prediction on the web: a case study using the Phyre server. Nat. Protoc. 4, 363-371 (2009).
20. Jones, D.T. Protein secondary structure prediction based on position-specifc scoring matrices. J. Mol. Biol. 292, 195-202 (1999).
21. Plechanovová, A., Jafray, E.G., Tatham, M.H., Naismith, J.H. & Hay, R.T. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 489, 115-120 (2012).
22. Grimsley, G.R., Scholtz, J.M. & Pace, C.N. A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci. 18, 247-251 (2009).
23. Sheng, Y. et al. A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-function screen. Mol. Cell. Proteomics 11, 329-341 (2012).
24. Vittal, V., Wenzel, D.M., Brzovic, P.S. & Klevit, R.E. Biochemical and structural characterization of the ubiquitin-conjugating enzyme UBE2W reveals the formation of a noncovalent homodimer. Cell Biochem. Biophys. 67, 103-110 (2013).
25. Laskowski, R.A. PDBsum new things. Nucleic Acids Res. 37, D355-D359 (2009).
26. Shen, Y. et al. Consistent blind protein structure generation from NMR chemical shit data. Proc. Natl. Acad. Sci. USA 105, 4685-4690 (2008).
27. Shen, Y., Vernon, R., Baker, D. & Bax, A. De novo protein structure generation from incomplete chemical shif assignments. J. Biol. NMR 43, 63-78 (2009).
28. Pruneda, J.N. et al. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Mol. Cell 47, 933-942 (2012).
29. Dou, H., Buetow, L., Sibbet, G.J., Cameron, K. & Huang, D.T. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat. Struct. Mol. Biol. 19, 876-883 (2012).
30. Wu, P. Y. et al. A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J. 22, 5241-5250 (2003)
31. Erratum 23, 4876 (2004)
32. Erratum 26, 4051 (2007).
33. Berndsen, C.E., Wiener, R., Yu, I.W., Ringel, A.E. & Wolberger, C. A conserved asparagine has a structural role in ubiquitin-conjugating enzyme. Nat. Chem. Biol. 9, 154-156 (2013).
34. Hershko, A., Heller, H., Eytan, E., Kaklij, G. & Rose, I.A. Role of the α-amino group of protein in ubiquitin-mediated protein breakdown. Proc. Natl. Acad. Sci. USA 81, 7021-7025 (1984).
35. Breitschopf, K., Bengal, E., Ziz, T., Admon, A. & Ciechanover, A. A novel site of ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 17, 5964-5973 (1998).
36. Ciechanover, A. & Ben-Saadon, R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14, 103-106 (2004).
37. Coulombe, P., Rodier, G., Bonneil, E., Tibault, P. & Meloche, S. N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 24, 6140-6150 (2004).
38. Dormeyer, W., Mohammed, S., Breukelen, B., Krijgsveld, J. & Heck, A.J. Targeted analysis of protein termini. J. Proteome Res. 6, 4634-4645 (2007).
39. Yin, G. et al. Cloning, characterization and subcellular localization of a gene encoding a human ubiquitin-conjugating enzyme (E2) homologous to the Arabidopsis thaliana UBC-16 gene product. Front. Biosci. 11, 1500-1507 (2006).
40. Pickart, C.M. & Raasi, S. Controlled synthesis of polyubiquitin chains. Methods Enzymol. 399, 21-36 (2005).
41. Brzovic, P.S. et al. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. USA 100, 5646-5651 (2003).
42. Todi, S.V. et al. Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity. J. Biol. Chem. 282, 29348-29358 (2007).
43. Barghorn, S., Biernat, J. & Mandelkow, E. Purifcation of recombinant tau protein and preparation of Alzheimer-paired helical flaments in vitro. Methods Mol. Biol. 299, 35-51 (2005).
44. Winborn, B.J. et al. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 283, 26436-26443 (2008).
45. Xu, Z. et al. Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. Biochemistry 45, 4749-4759 (2006).
46. Sattler, M., Schleucher, J. & Griesinger, C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed feld gradients. Prog. Nucl. Magn. Reson. Spectrosc. 34, 93-158 (1999).
47. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
48. Johnson, B.A. & Blevins, R.A. NMR View: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614 (1994).
49. Svergun, D., Barberato, C. & Koch, M.H.J. CRYSOL: A program to evaluate X-ray solution scatter of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768-773 (1995).
50. Raman, S. et al. NMR structure determination for larger proteins using backbone-only data. Science 327, 1014-1018 (2010).
51. Tompson, J.M. et al. Accurate protein structure modeling using sparse NMR data and homologous structure information. Proc. Natl. Acad. Sci. USA 109, 9875-9880 (2012).
52. Bhattacharya, A., Tejero, R. & Gaetano, M.T. Evaluating protein structures determined by structural genomics consortia. Proteins 66, 778-795 (2007).
53. Ulmer, T.S., Ramirez, B.E., Delaglio, F. & Bax, A. Evaluation of backbone proton positions and dynamics in a small protein by liquid crystal NMR spectroscopy. J. Am. Chem. Soc. 125, 9179-9191 (2003).